Search

everythinglearnresearchcommunity

for

Search:↓

A 68-year-old woman with benign mucous membrane pemphigoid has eye, mouth, and skin issues, including thick plaques and nail changes.

A woman with a rare autoimmune disorder had a blister on her eye and unique immune reaction, which was effectively treated with medication.

Patients with autoimmune blistering diseases experience a reduced quality of life, with the need for better measurement tools, especially for those with mucous membrane pemphigoid.

Most patients with blistering skin disorders in South India had bullous pemphigoid and often had other conditions like hypertension and diabetes.

Hair loss in autoimmune blistering skin diseases varies and may regrow with disease control.

Many patients with autoimmune blistering skin disorders change their diets, avoiding foods like alcohol, citrus, and spices, and some find vegetables and dairy helpful.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.

Collagen XVII is important for skin aging and wound healing.

Most patients with autoimmune blistering diseases experienced some hair loss, which may be underreported and linked to disease severity.

The research found that certain characteristics like age, sex, race, marital status, and education level can influence whether alopecia patients stick to their hair loss treatment with topical minoxidil.

Mycophenolate mofetil helped reduce steroid use in treating a dog's autoimmune skin disease.

Dupilumab is effective and safe for treating moderate-to-severe atopic dermatitis in adolescents.

VB1953 gel significantly reduced acne and resistant bacteria in patients who didn't respond to clindamycin.

Topical treatments led to hair regrowth in a man with linear morphea.

Sandalore®, a synthetic scent, improved hair loss and satisfaction in women with telogen effluvium.

Some skin conditions are associated with other serious diseases, and office microscopy may miss many fungal infections.

Vitiligo affects overall health and self-esteem, needing more research and awareness.

Smoking harms the skin, causing early aging and increasing cancer risk, but stopping smoking can improve skin health.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

Lichen planus is a chronic autoimmune disease that is hard to treat and more common in women.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

ROS may affect hair loss related to hormones.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Genetic marker rs12558842 strongly linked to male hair loss.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.